On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

When an FDA-approved drug is in shortage, compounding pharmacies may legally dispense generic versions for patients who can’t ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

It was semaglutide, a drug sold under the brand names Ozempic (for diabetes) and Wegovy (for weight loss). Following ...